Close
Help
Login
Staff Login
Register
0
Selected
Invert selection
Deselect all
Deselect all
Add to Cart
Click here to refresh results
Click here to refresh results
Go to Login page
New Brunswick reports blood clot death in connection with Oxford-AstraZeneca vaccine
New Brunswick reports blood clot death in connection with Oxford-AstraZeneca vaccine
New Brunswick reports blood clot death in connection with Oxford-AstraZeneca vaccine
Standard Video
Actions
Overview
Conceptually Similar Documents
CP122404571 | Quebec reports first blood clot death in woman who received AstraZeneca vaccine
CP123262421 | N.S. pauses use of AstraZeneca vaccine
CP121635062 | AstraZeneca vaccine to remain authorized in Canada
CP122017117 | AstraZeneca blood clot risk remains low: Tam
CP122904771 | B.C. records first case of rare blood clot related to vaccine
CP120960271 | Nova Scotia to expand use of Oxford-AstraZeneca vaccine to those 55-64
CP119781421 | N.S. to start administering AstraZeneca vaccines
CP120476771 | AstraZeneca vaccine's benefits vastly outweigh risks: Sharma
CP121946460 | Newly eligible people receive Oxford-AstraZeneca vaccine
CP123774871 | Ontario to resume AstraZeneca shots for COVID-19 as second dose
City
Vaughan
Country
Canada
Add to cart
Select usage
Type of video?
For editorial use only. Video needs to be used in its entirety (i.e. use of select segment(s) not allowed).
Audience Size
Usage description
Add to collection
Add to cart
New Brunswick reports blood clot death in connection with Oxford-AstraZeneca vaccine
Source name:
The Canadian Press
Unique identifier:
CP122830710
Legacy Identifier:
n_COVID-NB20210505T1507
Type:
Video
Duration:
2m20s
Dimensions:
1920px × 1080px 157.02 MB
Usage rights:
FOR ONE TIME USE ONLY. NO STORAGE FOR FUTURE USE.
Create Date:
5/5/2021 3:07:00 PM
Display aspect ratio:
16:9
Tags
blood clot
COVID-19
death
N.B.
Oxford-AstraZeneca
Vaccination
vaccine